Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk
about
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association studyLung cancer: epidemiology, etiology, and preventionAcute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threatsEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesGenetic variants and risk of lung cancer in never smokers: a genome-wide association studyTobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO)Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guidelineLung cancer in never smokersPrevious lung diseases and lung cancer risk: a systematic review and meta-analysisContext-Specific and Immune Cell-Dependent Antitumor Activities of α1-AntitrypsinDown-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysisChronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study.A rigorous and comprehensive validation: common genetic variations and lung cancerSerum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls.Identification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS.Identification of urine biomarkers associated with lung adenocarcinoma.Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk.Chronic obstructive pulmonary disease as a risk factor for lung cancerLung cancer screening: a review of available data and current guidelines.Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk.Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA.Association between chronic obstructive pulmonary disease and lung cancer: a case-control study in Southern Chinese and a meta-analysisEffect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment.Identification of a rare p.G320R alpha-1-antitrypsin variant in emphysema and lung cancer patientsIdentification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis.Mind-mapping for lung cancer: towards a personalized therapeutics approachGenetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy.Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.DNA methylation and RNA expression profiles in lung adenocarcinomas of never-smokers.Endogenous modifiers of cigarette smoke exposure within the lung.Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer.Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells.Secondhand Tobacco Smoke Exposure and Lung Adenocarcinoma In Situ/Minimally Invasive Adenocarcinoma (AIS/MIA).COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.Network-based approach identified cell cycle genes as predictor of overall survival in lung adenocarcinoma patients.Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersMultiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease.Stem cells and lung cancer: future therapeutic targets?Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival.
P2860
Q21261276-17D4F8F9-E21D-4959-BBEF-435685EB05A6Q24630167-F042EC34-EA1C-420E-8CCA-F654FC060724Q26858837-64DCFF7B-F3E4-4F25-B3FF-D2F8C17C7DBBQ27023830-20FF7424-EDCA-4195-A739-258492B3589CQ28383607-647F75E9-D62C-4A60-BDB0-592B3C187FB6Q28385243-0330007B-245A-4E3F-AB58-07A4311962D1Q28385458-56354263-2E9D-4333-A025-951D0797D225Q28386853-78BB2B0E-442C-4219-B303-75EF3C5EAB8EQ28387390-CEC1025A-0839-42FA-A5D0-794AC3F285B7Q28817846-E70FFB0C-18DC-4958-BEE8-BC4250A9C394Q33475812-42348605-0DD8-4732-B6EE-0D449858237AQ33509281-D131C993-0C99-4960-B4B0-A916D74F7FF4Q33586584-9BC6C6EF-13EB-4C98-9F57-D23BEFED2240Q33656312-27617968-A96D-4C7B-BCA5-12FDB90F71D9Q33815416-DD307E95-2E0C-41FF-A666-872453BEDF83Q33888856-700AB62E-B6F8-44E1-831E-8E01FE2F9346Q33952622-1F46C8BB-BD9A-43E3-B854-14AC027312EDQ34031235-35093441-02DD-40ED-A323-42A5991A5D42Q34067949-E554FA2C-255E-4DBE-A0DC-99AA09179CC8Q34183548-ADA28875-6DFF-477E-85A9-F9CDF03DBEE7Q34396256-E83E876D-E182-420E-910B-8A9F472ECDEDQ34430876-E203FA32-729C-4F24-B8AD-2603844795CFQ34476776-A05356C5-44E6-458C-B5E5-E93F27CF2116Q34562581-74C8C52E-5178-44A1-A77D-56AA0330E460Q34683513-2D0A00F6-E9BF-4621-B471-2AB5C5490BC4Q34796086-7C56C0AE-C2D5-4BA9-B053-3279F3833C33Q35072797-578FB8A4-19F9-4935-8826-4A4B4D8E61A0Q35196480-9E9BA7D3-F6A5-4F26-BCA2-8FCC32F3B7F0Q35675274-BE6D4431-D67B-4372-BB88-47115C521789Q35738383-DC769ECB-A410-4188-B8BA-BEF51B23F842Q35984007-3D17B4AA-84E5-4A87-B0FA-7A64D8ADC353Q36148775-9699275C-7AC9-476A-A72D-81A8C575A6ADQ36386977-973269BF-CF84-4CB4-80E8-A34BFD3BC1FAQ36524981-A8D8A2AD-7A70-46AA-9E7F-8B22CDAED9B8Q36546997-D0707756-514D-4A6B-9374-00304E278643Q36677842-C8B1B05A-8A41-4829-AC2B-D14B121582DBQ37037246-344BF1D1-500F-4F19-AF97-199F4628E56DQ37536837-3BC58B6D-2B96-4F3F-B452-79D3A5287064Q37571960-454CBDB4-EA04-42A2-B4AF-BF2FD0B3B23BQ37591139-4771E76F-C226-4FD6-BE84-F2C333246A8F
P2860
Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Alpha1-antitrypsin deficiency ...... disease, and lung cancer risk
@en
type
label
Alpha1-antitrypsin deficiency ...... disease, and lung cancer risk
@en
prefLabel
Alpha1-antitrypsin deficiency ...... disease, and lung cancer risk
@en
P2093
P2860
P1476
Alpha1-antitrypsin deficiency ...... disease, and lung cancer risk
@en
P2093
David E Midthun
Jason A Wampfler
Jerry A Katzmann
Marie-Christine Aubry
Mariza de Andrade
Mark S Allen
Michael J Krowka
Randolph S Marks
Stephen N Thibodeau
P2860
P304
P356
10.1001/ARCHINTE.168.10.1097
P407
P577
2008-05-01T00:00:00Z